Explore Baker Brothers' biotech-focused 13F portfolio, with notable stake increases in Incyte, Summit Therapeutics, and other ...

We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take ...

In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report), with a ...

Barclays analyst Peter Lawson assigned a Buy rating to Nurix Therapeutics (NRIX – Research Report) today and set a price target of $31.00. The ...

Fintel reports that on December 10, 2024, BTIG initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a Buy ...

For our list of the worst Ark stocks to buy according to short sellers, we ranked the 110 largest holdings in Ark Invest’s Q3 ...

BMO Capital Markets started coverage on shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) in a report released on ...

During the last three months, 9 analysts shared their evaluations of Nurix Therapeutics NRIX, revealing diverse outlooks from ...

Fintel reports that on December 6, 2024, BMO Capital initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a ...